Determination of olmesartan medoxomil in tablets by UV-Vis spectrophotometry

Pharmazie

Volumn 62, Issue 6, 2007, Pages 419-422

  Celebier, M ^a   Altinoz, Sacide ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; OLMESARTAN; SODIUM HYDROXIDE;

ACCURACY; ARTICLE; DRUG DETERMINATION; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ACETONITRILES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; IMIDAZOLES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SODIUM HYDROXIDE; SOLUTIONS; SOLVENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS; TETRAZOLES;

EID: 34250832716     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.6.6233     Document Type: Article

References (12)

1. Braggio S, Barnaby RJ, Grossi P, Cugola MA (1996) A strategy for validation of bioanalytical methods. J Pharm Biomed Anal 14: 375-388.
2. Ermer J, Ploss HJ (2005) Validation in pharmaceutical analysis, part II: central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data. J Pharm Biomed Anal 37: 859-870.
3. Fabre H, Altria KD (2001) Validating CE methods for pharmaceutical analysis. LC-GC 14: 302-310.
4. Green JM (1996) A practical guide to analytical method validation. Anal Chem 68: 305A-309A.
5. ICH Topic Q2A (1995) Validation of analytical procedures: methodology, CPMP/ICH/281/95.
6. Koike H, Konse T, Sada T, Ikeda T, Hyogo A, Hinman D, Saito H, Yanagisawa H (2003) Olmesartan medoxomil, a novel potent angiotensin II blocker. Ann Rep Sankyo Res Lab 55: 1-91.
7. Mire DE, Silfani TN, Pugsley MK (2005) A review of the structural and functional features of olmesartan medoxomil, an angiotensin receptor blocker. J Cardiovasc Pharmacol 46: 585-593.
8. Nemutlu E, Yardimci C, Ozaltin N (2005) Determination of sertaconazole in pharmaceutical preparations by capillary zone electrophoresis. Anal Chim Acta 547: 83-88.
9. Tavemiers I, Loose MD, Bockstaele EV (2004) Trends in the analytical laboratory. II. Analytical method validation and quality assurance. Trends Anal Chem 23: 535-552.
10. Ulu ST, Saglik S (2004) Comparison of UV and second derivative spectrophotometric and high-performance liquid chromatographic methods for the determination of losartan in tablets. Turk J Pharm Sci 1: 165-175.
11. Unger T, Mclnnes GT, Neutel JM, Bohm M (2004) The Role of olmesartan medoxomil in the management of hypertension. Drugs 64: 2731-2739.
12. Vander Heyden Y, Nijhuis A, Smeyers-Vebreke J, Vandeginste BGM, Massart DL (2001) Guidance for robustness/ruggedness tests in method validation. J Pharm Biomed Anal 24: 723-753.